Healon EndoCoat Protective Gel for Cataract Surgery From Abbott Approved by FDA
July 6, 2012
Abbott Laboratories (NYSE: ABT) announced earlier this week that the FDA had approved Healon EndoCoat gel, whichi is intended for use as a surgical aid in cataract extraction and intraocular lens (IOL) implantation.
Part of Abbott’s Healon® family of ophthalmic viscosurgical devices (OVDs), the clear, viscous, protective Healon EndoCoat gel formula is injected into a patient’s eye to protect and coat the eye during surgery, reducing trauma to the inside layer of the cornea and other surrounding tissues.
Abbott added that the surgical delivery system for Healon EndoCoat OVD includes a number of features for increased patient safety and ease of handling for the physician, including a smaller delivery device and improved ergonomics for a smooth and consistent delivery of the formula into the eye.
Click here to read the full press release.
I invite any readers who have used Abbott’s Healon products to provide feedback.
You might also enjoy...
- Healon EndoCoat Protective Gel for Cataract Surgery Granted CE Mark by EU
- Abbott Labs Completes Purchase of Producer of Advanced Refractive Technologies
- Abbott Introduces Micro-Implantation Cataract Surgery Tools
- DisCoVisc is a Safe Alternative to Healon According to A Presentation at Canadian Ophthalmological Society
- FDA Approves New Cataract Multifocal Intraocular Lens From Abbott
Comments
Jump down to form below to submit your own comments
